ENL - Enaleni Pharmaceuticals Limited - Dealing in
ENL
ENL
ENL - Enaleni Pharmaceuticals Limited - Dealing in securities by directors
Enaleni Pharmaceuticals Limited
(Incorporated in the Republic of South Africa)
(Registration number 2002/018027/06)
(JSE code: ENL & ISIN: ZAE000067740)
("Enaleni")
DEALING IN SECURITIES BY DIRECTORS
In terms of paragraph 3.63 - 3.65 of the JSE Limited Listings Requirements, the
following information relates to the sale of ordinary shares by a director of
Enaleni:
Executive director: C Aucamp
Company: Enaleni
Number of shares: 150 000
Price per share: 400 cents per share
Value of transaction: R600 000
Extent of interest: Indirect beneficial
Date of transaction: 22 November 2007
Nature of transaction: Shares sold on the open market
Written clearance to deal obtained: Yes
Executive Director: D Watermeyer
Company: Cipla-Medpro (Pty) Ltd
Number of shares: 150 000
Price per share: 400 cents per share
Value of transaction: R600 000
Extent of interest: Indirect beneficial
Date of transaction: 22 November 2007
Nature of transaction: Shares sold on the open market
Written clearance to deal obtained: Yes
Johannesburg
22 November 2007
Sponsor
Nedbank Capital
Date: 22/11/2007 16:09:01 Produced by the JSE SENS Department.
The SENS service is an information dissemination service administered by the
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or
implicitly, represent, warrant or in any way guarantee the truth, accuracy or
completeness of the information published on SENS. The JSE, their officers,
employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature,
howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
